💨 Abstract

President Donald Trump plans to sign an executive order linking Medicare's drug prices to the lowest prices paid by other countries, a move dubbed the "most favored nation" policy. Aimed at reducing healthcare costs for Americans, the proposal faces backlash from the pharmaceutical industry, which argues it could hinder investment and research into new drugs. The order is expected to primarily affect drugs administered in doctor's offices, potentially saving the government billions but not trillions, as Trump claimed.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖